MNKD MannKind Corporation - Common Stock
$4,34
Prezzo · Ago 20, 2026
Fondamentali al Ago 5, 2026
Intervallo 52 sett.
$2–$7
49% of range
Rating Analisti
BUY
14 analysts
Prezzo Obiettivo
$8
+84% upside
P/E (TTM)
216.8
ROE
-11.1%
Margine di Profitto Netto
1.7%
Informazioni su MannKind Corporation - Common Stock Panoramica della società da Wikipedia
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
Leggi di più
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann.
History
Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology. Pharmaceutical Discovery was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin).
The FDA approved Afrezza on June 27, 2014.
On August 11, 2014 MannKind entered into an exclusive global licensing agreement with Sanofi for Afrezza sales. Under the agreement, MannKind received $150 million cash from Sanofi, in exchange for sharing profits and losses of sales of Afrezza, with 65% for Sanofi and 35% for MannKind. On January 5, 2016, MannKind Corporation announced the termination of the license and collaboration agreement with Sanofi. By December 2017, the company had lost 11% of its trading volume due to the poor sales.
In March 2020, the company announced it was working with fellow pharmaceutical company Immix Biopharma to try to develop an inhalable treatment for acute respiratory distress syndrome, a lung disease.
Products and product candidates
The firm has developed Afrezza a rapid-acting insulin peaking 12 to 15 minutes after inhalation and exiting the body within 2–3 hours. The inhalation technology uses a miniature, breath-powered inhaler in combination with single-use cartridges containing pre-metered doses. Initial pharmacokinetic studies were followed by studies of safety and efficiency involving Technosphere formulations of different therapeutic proteins.
Leadership
Mann was chief executive officer until January 12, 2015 when Hakan Edstrom became CEO and Mann transitioned to executive chairman.
In November 2015, Hakan Edstrom stepped down as CEO and president. Company founder Alfred Mann stepped in as interim CEO on November 19, 2015. In 2016, Matthew Pfeffer was appointed CEO of MannKind, and served as both CEO and CFO. In May 2017, Michael Castagna was named CEO of the company.
Facilities
MannKind has a large corporate office in Westlake Village, California. The Afrezza manufacturing facility is in Danbury, Connecticut. In 2022, the company moved its official headquarters to Danbury.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
MNKD Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$4.33
Capitalizzazione di Mercato
$1.33B
P/E (TTM)
216.8
EPS (TTM)
$0.02
Ricavi (TTM)
$349M
Rendimento div.
—
ROE
-11.1%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$2 – $7
MNKD Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$349M
2016-12-31
→
2025-12-31
EPS
$0.02
2016-12-31
→
2025-12-31
Flusso di cassa libero
$14M
2018-12-31
→
2025-12-31
Margini
1.7%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
MNKD
Mediana dei peer
P/E (TTM)
216.8
—
P/S (TTM)
3.8
10.7
P/B
-26.2
5.2
Price / FCF (Prezzo / FCF)
97.5
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
MNKD
Mediana dei peer
Operating Margin (Margine Operativo)
11.1%
—
Net Profit Margin (Margine di Profitto Netto)
1.7%
-140.3%
ROA
0.99%
-44.7%
ROE
-11.1%
-51.5%
ROIC
-316.9%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
MNKD
Mediana dei peer
Current Ratio (Rapporto corrente)
1.7
9.5
Quick Ratio
1.2
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
MNKD
Mediana dei peer
Revenue YoY (Ricavi YoY)
22.2%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
51.8%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
39.9%
—
EPS YoY
-80.0%
—
Net Income YoY (Utile Netto YoY)
-78.8%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
MNKD
Mediana dei peer
MNKD Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
14 analisti
- Acquisto forte 4 28,6%
- Compra 8 57,1%
- Mantieni 2 14,3%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
8 analisti · 2026-08-17
Mediana
$7.50
← Sotto tutti i target
$4.33
Basso
$4.75
Alto
$13.00
Target mediano
$7.50
+73,0%
Target medio
$7.97
+83,8%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.03%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-0.06 | $-0.00 | -0.06% |
| 31 Marzo 2026 | $-0.05 | $-0.00 | -0.05% |
| 31 Dicembre 2025 | $-0.05 | $0.01 | -0.06% |
| 30 Settembre 2025 | $0.07 | $0.02 | 0.05% |
| 30 Giugno 2025 | $0.00 | $0.05 | -0.05% |
| 31 Marzo 2025 | $0.04 | $0.04 | -0.00% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| AVBP | $854M | -4.7 | — | — | -59.7% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| CGEM | $624M | -3.2 | — | — | -44.0% | — |
| JBIO | $761M | -4.8 | — | — | -47.7% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| AKTS | — | — | — | — | — | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 16
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Cost of Revenue | $27M | $17M | $21M | $16M | $17M | $15M | $20M | $19M | $17M | $17M | $65M | · | |
| SG&A Expense | $144M | $94M | $94M | $91M | $32M | $25M | $75M | $80M | $75M | $47M | $41M | $79M | |
| Operating Expenses | $88M | $77M | $63M | $57M | $39M | $25M | $108M | $104M | $120M | $107M | $345M | $180M | |
| Operating Income | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-108M | $67M | $-345M | $-180M | |
| Interest Expense | · | · | $15M | $15M | $15M | · | · | · | · | · | $24M | $20M | |
| Interest Income | $8M | $13M | $6M | $3M | $112.0K | $167.0K | $997.0K | $501.0K | $293.0K | $85.0K | $18.0K | $9.0K | |
| Other Non-op | $-1M | $32.0K | $122.0K | $-102.0K | $-239.0K | $23.0K | $-926.0K | $-437.0K | $13.0K | $-597.0K | $1M | $2M | |
| Pretax Income | $1M | $31M | $-10M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Income Tax | $-4M | $3M | $2M | $0 | $0 | $-218.0K | $0 | $240.0K | $51.0K | $0 | $0 | $0 | |
| Net Income | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| EPS (Basic) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.37 | $-4.54 | $-2.57 | |
| EPS (Diluted) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.36 | $-4.54 | $-2.57 | |
| Shares (Basic) | 305,639,000 | 274,415,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,053,000 | 81,233,000 | 77,045,000 | |
| Shares (Diluted) | 314,112,000 | 283,844,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,085,000 | 81,233,000 | 77,045,000 | |
| EBITDA | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-106M | · | $-334M | $-170M |
Stato Patrimoniale 28
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $75M | $46M | $238M | $70M | $124M | $67M | $30M | $71M | $44M | $23M | $59M | $121M | |
| Short-term Investments | $96M | $151M | $57M | $101M | $80M | $0 | $20M | · | · | · | · | · | |
| Receivables | $38M | $12M | $15M | $17M | $5M | $4M | $4M | $4M | $3M | $302.0K | $23.0K | $50M | |
| Inventory | $35M | $28M | $29M | $22M | $7M | $5M | $4M | $4M | $3M | $2M | · | $10M | |
| Prepaid Expense | $47M | $31M | $35M | $25M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $20M | |
| Current Assets | $292M | $268M | $373M | $235M | $219M | $79M | $61M | $82M | $57M | $77M | $77M | $201M | |
| PP&E (Net) | $82M | $85M | $84M | $45M | $37M | $26M | $27M | $26M | $27M | $29M | $49M | $192M | |
| PP&E (Gross) | $196M | $192M | $186M | $144M | $134M | $123M | $122M | $126M | $128M | $129M | $168M | $310M | |
| Accum. Depreciation | $114M | $107M | $102M | $99M | $98M | $97M | $95M | $100M | $101M | $100M | $120M | $118M | |
| Goodwill | $68M | $2M | $2M | $2M | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $5M | $1M | $1M | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $20M | $27M | $7M | $10M | $8M | $3M | $6M | $249.0K | $437.0K | $648.0K | $1M | $848.0K | |
| Total Assets | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Accounts Payable | $9M | $7M | $10M | $11M | $7M | $6M | $5M | $5M | $7M | $3M | $16M | $7M | |
| Accrued Liabilities | $65M | $40M | $42M | $36M | $27M | $20M | $16M | $15M | $12M | $8M | $8M | $26M | |
| Short-term Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Current Liabilities | $171M | $82M | $104M | $67M | $48M | $74M | $66M | $75M | $88M | $92M | $268M | $403M | |
| Capital Leases | $11M | $12M | $4M | $5M | $1M | $1M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $5M | · | · | · | · | · | $15M | $12M | |
| Total Liabilities | $843M | $473M | $721M | $546M | $531M | $289M | $284M | $283M | $299M | $291M | $477M | $468M | |
| Long-term Debt | $355M | $36M | $269M | $273M | $281M | $122M | $119M | $102M | $157M | · | · | · | |
| Total Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $4M | $4M | |
| Retained Earnings | $-3.20B | $-3.20B | $-3.23B | $-3.22B | $-3.13B | $-3.05B | $-2.99B | $-2.94B | $-2.85B | $-2.74B | $-2.86B | $-2.49B | |
| AOCI | $115.0K | $1M | · | · | · | · | $-19.0K | $-19.0K | $-18.0K | $-24.0K | $-20.0K | $-14.0K | |
| Stockholders' Equity | $-51M | $-79M | $-246M | $-251M | $-209M | $-180M | $-191M | $-175M | $-215M | $-184M | $-350M | $-74M | |
| Liabilities + Equity | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Shares Outstanding | 307,832,587 | 302,959,782 | 270,034,495 | 263,793,305 | 251,477,562 | 242,117,089 | 211,787,573 | 187,029,967 | 119,053,414 | 95,680,831 | 85,734,188 | 406,059,089 |
Flusso di cassa 18
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $7M | $5M | $3M | $2M | $2M | $972.0K | $3M | $2M | $2M | $11M | $10M | |
| Stock-based Comp | $24M | $21M | $18M | $13M | $12M | $7M | $6M | $7M | $5M | $5M | $9M | $49M | |
| Deferred Tax | $-19M | $4M | $7M | $-10M | $-20M | $-5M | $-5M | $-11M | $-260M | $48M | $-80M | $-66M | |
| Amort. of Intangibles | $4M | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $6M | $2M | |
| Other Non-cash | · | · | · | · | · | · | · | · | $306M | · | $291M | $144M | |
| Operating Cash Flow | $18M | $43M | $34M | $-81M | $-62M | $-28M | $-88M | $-38M | $-65M | $-78M | $-57M | $4M | |
| CapEx | $5M | $10M | $42M | $8M | $11M | $801.0K | $3M | $354.0K | · | $1M | $10M | $24M | |
| Investing Cash Flow | $-305M | $-97M | $-2M | $5M | $-152M | $15M | $-23M | $-234.0K | $17M | $-1M | · | · | |
| Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | $20M | |
| Net Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $564.0K | $893.0K | $28M | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $564.0K | · | $28M | · | |
| Financing Cash Flow | $315M | $-137M | $137M | $21M | $270M | $50M | $70M | $61M | $74M | $43M | · | · | |
| Net Change in Cash | $29M | $-191M | $169M | $-54M | $57M | $37M | $-41M | $23M | $25M | $-36M | $-62M | $50M | |
| Taxes Paid | $2M | $4M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $14M | $33M | $-8M | $-88M | $-73M | $-29M | $-91M | $-38M | · | · | $-68M | $-20M | |
| Levered FCF | · | · | $-26M | $-98M | · | · | · | · | · | · | $-92M | · |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -921.1% | · | · | · | |
| Net Margin | 1.7% | 9.7% | -6.0% | -87.6% | -107.3% | -87.9% | -82.3% | -312.2% | -999.0% | · | · | · | |
| Pretax Margin | 0.40% | 10.7% | -5.2% | -87.6% | -107.3% | -88.2% | -82.3% | -311.3% | -998.6% | · | · | · | |
| EBITDA Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -905.8% | · | · | · | |
| ROA | 0.99% | 6.3% | -3.1% | -28.4% | -37.7% | -56.6% | -51.5% | -90.5% | -122.4% | · | -141.5% | -60.8% | |
| ROE | -11.1% | -19.1% | 4.8% | 35.8% | 41.1% | 31.2% | 27.7% | 45.7% | 58.9% | · | 173.8% | 379.7% | |
| ROIC | -316.9% | -83.2% | -4.1% | 25.6% | 22.5% | 26.5% | 24.0% | 43.9% | 50.4% | · | 98.4% | · |
Liquidità e Solvibilità 4
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 | 1.1 | 0.9 | 1.1 | 0.7 | · | 0.3 | 0.5 | |
| Quick Ratio | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 | 1.0 | 0.8 | 1.0 | 0.5 | · | 0.2 | 0.4 | |
| Debt / Equity | · | · | · | · | · | · | -0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | 0.6 | -6.7 | · | · | · | · | · | · | -14.3 | -8.8 |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.6 | 0.3 | 0.1 | · | 0.0 | · | |
| Inventory Turnover | 0.8 | 0.6 | 0.8 | 1.1 | 2.8 | 3.3 | 5.2 | 6.2 | 6.9 | · | · | · | |
| Receivables Turnover | 13.9 | 21.4 | 12.6 | 9.3 | 16.4 | 16.9 | 16.7 | 8.2 | 7.6 | · | 0.0 | · |
Tassi di Crescita 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 22.2% | 43.5% | 99.4% | 32.2% | 15.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 51.8% | 55.8% | 45.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 39.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -80.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -78.8% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 13
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Net Income TTM | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Market Cap | $1.75B | $1.95B | $983M | $1.39B | $1.10B | $758M | $273M | $198M | $276M | · | $3.11B | $10.60B | |
| Enterprise Value | · | · | · | · | · | · | $228M | · | · | · | · | · | |
| P/E | 283.5 | 64.3 | -91.0 | -15.5 | -13.7 | -12.0 | -2.0 | -1.8 | -2.1 | 2.4 | -1.6 | -10.2 | |
| P/S | 5.0 | 6.8 | 4.9 | 13.9 | 14.6 | 11.6 | 4.3 | 7.1 | 23.5 | · | · | · | |
| P/B | -34.2 | -24.7 | -4.0 | -5.5 | -5.2 | -4.2 | -1.4 | -1.1 | -1.3 | · | -8.9 | -143.7 | |
| P / Cash Flow | 95.6 | 45.8 | 28.8 | -17.2 | -17.8 | -26.9 | -3.1 | -5.3 | -4.3 | · | -54.3 | 2593.8 | |
| P / FCF | 127.5 | 59.4 | -117.8 | -15.7 | -15.0 | -26.2 | -3.0 | -5.2 | · | · | -46.0 | -529.6 | |
| EV / EBITDA | · | · | · | · | · | · | -5.1 | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | -2.5 | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | 3.6 | · | · | · | · | · | |
| Earnings Yield | 0.35% | 1.6% | -1.1% | -6.5% | -7.3% | -8.3% | -48.8% | -56.6% | -48.7% | 42.5% | -62.6% | -9.8% |
Conto Economico 16
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109M | $90M | $112M | $82M | $77M | $78M | $77M | $70M | $72M | $66M | $58M | $51M | $49M | $41M | $36M | $33M | |
| Cost of Revenue | $14M | $8M | $14M | $4M | $5M | $4M | $5M | $3M | $6M | $4M | $6M | $4M | $5M | $6M | $4M | $5M | |
| SG&A Expense | $58M | $54M | $58M | $29M | $32M | $25M | $24M | $24M | $24M | $22M | $61M | $11M | $12M | $11M | $64M | $9M | |
| Operating Expenses | $30M | $92M | $-103M | $63M | $21M | $56M | $-86M | $57M | $56M | $50M | $18M | $14M | $14M | $16M | $16M | $17M | |
| Operating Income | $-350.0K | $-2M | $-8M | $19M | $5M | $22M | $26M | $13M | $17M | $17M | $8M | $5M | $2M | $-6M | $-13M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | $6M | $3M | · | $3M | $7M | $3M | · | $3M | |
| Interest Income | $1M | $1M | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $663.0K | |
| Other Non-op | $-5M | $-3M | $23M | $-11M | $-4M | $-9M | $24M | $110.0K | $-18M | $-6M | $-164.0K | $318.0K | $-143.0K | $111.0K | $105.0K | $-207.0K | |
| Pretax Income | $-19M | $-16M | $-21M | $8M | $940.0K | $14M | $8M | $13M | $-2M | $11M | $3M | $2M | $-5M | $-10M | $-18M | $-14M | |
| Income Tax | $-106.0K | $253.0K | $-5M | $-204.0K | $272.0K | $459.0K | $1M | $1M | $323.0K | $264.0K | $2M | $0 | $0 | $0 | · | $0 | |
| Net Income | $-19M | $-17M | $-16M | $8M | $668.0K | $13M | $7M | $12M | $-2M | $11M | $1M | $2M | $-5M | $-10M | $-18M | $-14M | |
| EPS (Basic) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| EPS (Diluted) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| Shares (Basic) | 309,191,000 | 308,267,000 | -609,602,000 | 306,806,000 | 304,954,000 | 303,481,000 | -543,995,000 | 274,998,000 | 273,056,000 | 270,356,000 | -531,313,000 | 268,732,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| Shares (Diluted) | 309,191,000 | 308,267,000 | -629,907,000 | 311,638,000 | 311,484,000 | 320,897,000 | -598,638,000 | 284,693,000 | 273,056,000 | 324,733,000 | -586,351,000 | 323,770,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| EBITDA | · | $-2M | · | $19M | $5M | $22M | · | $13M | $17M | $17M | · | $5M | $2M | $-6M | · | $-10M |
Stato Patrimoniale 25
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $53M | $53M | $75M | $127M | $57M | $47M | $46M | $62M | $97M | $193M | · | $83M | $86M | $86M | · | $54M | |
| Short-term Investments | $58M | $81M | $96M | $133M | $122M | $134M | $151M | $189M | $151M | $107M | · | $58M | $58M | $80M | · | $111M | |
| Receivables | $43M | $28M | $38M | $17M | $27M | $29M | $12M | $18M | $23M | $20M | · | $22M | $28M | $20M | · | $23M | |
| Inventory | $44M | $49M | $35M | $27M | $28M | $29M | $28M | $27M | $25M | $26M | · | $27M | $25M | $22M | · | $18M | |
| Prepaid Expense | $47M | $40M | $47M | $54M | $44M | $34M | $31M | $31M | $30M | $36M | · | $36M | $33M | $15M | · | $12M | |
| Current Assets | $246M | $251M | $292M | $359M | $279M | $274M | $268M | $328M | $326M | $383M | · | $226M | $230M | $223M | · | $218M | |
| PP&E (Net) | $85M | $83M | $82M | $83M | $83M | $84M | $85M | $85M | $85M | $84M | · | $80M | $70M | $55M | · | $41M | |
| PP&E (Gross) | $203M | $198M | $196M | $195M | $194M | $192M | $192M | $192M | $190M | $186M | · | $182M | $170M | $154M | · | $140M | |
| Accum. Depreciation | $118M | $116M | $114M | $113M | $111M | $109M | $107M | $107M | $105M | $103M | · | $101M | $100M | $100M | · | $99M | |
| Goodwill | $68M | $68M | $68M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $3M | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Other Non-current Assets | $17M | $22M | $20M | $19M | $20M | $28M | $27M | $26M | $16M | $7M | · | $8M | $8M | $16M | · | $17M | |
| Total Assets | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Accounts Payable | $11M | $16M | $9M | $7M | $10M | $5M | $7M | $6M | $10M | $7M | · | $17M | $17M | $14M | · | $10M | |
| Accrued Liabilities | $61M | $59M | $65M | $31M | $31M | $40M | $40M | $37M | $41M | $42M | · | $32M | $37M | $33M | · | $30M | |
| Current Liabilities | $143M | $135M | $171M | $109M | $112M | $116M | $82M | $72M | $80M | $100M | · | $96M | $97M | $82M | · | $60M | |
| Capital Leases | $10M | $10M | $11M | $10M | $11M | $11M | $12M | $12M | $3M | $4M | · | $4M | $5M | $5M | · | $6M | |
| Total Liabilities | $800M | $804M | $843M | $539M | $467M | $469M | $473M | $674M | $670M | $711M | · | $572M | $574M | $554M | · | $532M | |
| Long-term Debt | $319M | $319M | $355M | $110M | $36M | $36M | $36M | $228M | $228M | $264M | · | $273M | $274M | $274M | · | $273M | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Retained Earnings | $-3.23B | $-3.21B | $-3.20B | $-3.18B | $-3.19B | $-3.19B | $-3.20B | $-3.21B | $-3.22B | $-3.22B | · | $-3.23B | $-3.23B | $-3.23B | · | $-3.20B | |
| AOCI | $-19.0K | $-4.0K | $115.0K | $137.0K | $1M | $1M | $1M | $588.0K | · | · | · | $443.0K | $443.0K | · | · | $-1M | |
| Stockholders' Equity | $-67M | $-59M | $-51M | $-45M | $-55M | $-59M | $-79M | $-210M | $-226M | $-230M | $-246M | $-252M | $-260M | $-255M | $-251M | $-238M | |
| Liabilities + Equity | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Shares Outstanding | 309,911,682 | 308,907,331 | 307,832,587 | 307,027,189 | 306,332,133 | 303,918,969 | 302,959,782 | 275,775,038 | 274,467,247 | 270,801,781 | · | 269,543,539 | 268,235,145 | 264,278,760 | · | 263,156,165 |
Flusso di cassa 11
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $-427.0K | |
| Stock-based Comp | $10M | $6M | $7M | $4M | $8M | $5M | $6M | $5M | $6M | $4M | $4M | $5M | $6M | $4M | $3M | $4M | |
| Amort. of Intangibles | $4M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-18M | $-5M | $-8M | $24M | $9M | $-6M | $23M | $9M | $4M | $7M | $22M | $9M | $3M | $1M | $-2M | $-28M | |
| CapEx | $5M | $2M | $2M | $1M | $1M | $330.0K | $3M | $1M | $3M | $2M | $6M | $11M | $17M | $8M | $5M | $271.0K | |
| Investing Cash Flow | $18M | $19M | $-292M | $-25M | $6M | $6M | $48M | $-41M | $-55M | $-48M | $-8M | $-12M | $4M | $14M | $15M | $27M | |
| Financing Cash Flow | $559.0K | $-35M | $247M | $72M | $-6M | $1M | $-87M | $-2M | $-45M | $-3M | $142M | $-283.0K | $-6M | $1M | $3M | $20M | |
| Net Change in Cash | $97.0K | $-22M | $-53M | $70M | $10M | $975.0K | $-16M | $-34M | $-96M | $-45M | $155M | $-3M | $315.0K | $16M | $15M | $19M | |
| Taxes Paid | $753.0K | $63.0K | $549.0K | $80.0K | $869.0K | $207.0K | $2M | $236.0K | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-7M | · | · | · | $-7M | · | · | · | $4M | · | · | · | $-7M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $2M | · | · | · | $-10M | · | · |
Redditività 7
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| Net Margin | · | -18.4% | · | 9.7% | 0.87% | 16.8% | · | 16.5% | -2.8% | 16.0% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| Pretax Margin | · | -18.1% | · | 9.5% | 1.2% | 17.4% | · | 18.4% | -2.3% | 16.4% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| EBITDA Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| ROA | · | -2.9% | · | 1.7% | 0.16% | 2.9% | · | 2.9% | -0.53% | 2.7% | · | 0.56% | -1.8% | -3.2% | · | -5.4% | |
| ROE | · | 28.2% | · | -6.3% | -0.48% | -9.1% | · | -5.0% | 0.83% | -4.4% | · | -0.70% | 2.1% | 4.0% | · | 6.8% | |
| ROIC | · | 2.9% | · | -43.5% | -6.8% | -36.8% | · | -5.5% | -8.8% | -7.1% | · | -2.0% | -0.66% | 2.4% | · | · |
Liquidità e Solvibilità 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 3.3 | 2.5 | 2.4 | · | 4.5 | 4.1 | 3.8 | · | 2.3 | 2.4 | 2.7 | · | 3.7 | |
| Quick Ratio | · | 1.2 | · | 2.5 | 1.8 | 1.8 | · | 3.7 | 3.4 | 3.2 | · | 1.7 | 1.8 | 2.3 | · | 3.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 2.7 | 6.5 | · | 1.8 | 0.3 | -2.5 | · | · |
Efficienza 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.4 | |
| Receivables Turnover | 3.1 | 3.2 | · | 4.6 | 3.0 | 3.2 | · | 3.5 | 2.8 | 3.3 | · | 2.3 | 2.3 | 2.8 | · | 2.0 |
Valutazione (TTM) 9
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $358M | $327M | · | $307M | $297M | $287M | · | $260M | $239M | $207M | · | $173M | $141M | $104M | · | $86M | |
| Net Income TTM | $-27M | $5M | · | $33M | $23M | $33M | · | $22M | $5M | $-3M | · | $-28M | $-59M | $-79M | · | $-74M | |
| Market Cap | $1.32B | $757M | · | $1.65B | $1.15B | $1.53B | · | $1.73B | $1.43B | $1.23B | · | $1.11B | $1.09B | $1.08B | · | $813M | |
| P/E | -53.2 | 122.5 | · | 48.8 | 53.4 | 45.7 | · | 78.6 | 261.0 | -453.0 | · | -37.5 | -17.7 | -13.2 | · | -10.7 | |
| P/S | 3.7 | 2.3 | · | 5.4 | 3.9 | 5.3 | · | 6.7 | 6.0 | 5.9 | · | 6.4 | 7.7 | 10.4 | · | 9.5 | |
| P/B | -19.6 | -12.8 | · | -37.0 | -20.8 | -26.1 | · | -8.3 | -6.3 | -5.3 | · | -4.4 | -4.2 | -4.2 | · | -3.4 | |
| P / Cash Flow | · | -141.1 | · | · | · | -239.7 | · | · | · | 183.0 | · | · | · | 937.3 | · | · | |
| P / FCF | · | -104.5 | · | · | · | -227.9 | · | · | · | 285.6 | · | · | · | -151.4 | · | · | |
| Earnings Yield | -1.9% | 0.82% | · | 2.1% | 1.9% | 2.2% | · | 1.3% | 0.38% | -0.22% | · | -2.7% | -5.7% | -7.6% | · | -9.4% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $349M | $286M | $199M | $100M | $75M |
| Margine Operativo % | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% |
| Utile netto | $6M | $28M | $-12M | $-87M | $-81M |
| EPS Diluito | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 |
| Quick Ratio | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $14M | $33M | $-8M | $-88M | $-73M |
Ultime notizie Notizie recenti che menzionano questa società
- Wells Fargo Calls MannKind Corporation (MNKD)’s Commercial Potential a “Show-Me Story”
- MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy
- H.C. Wainwright e Wells Fargo Aumentano i Price Target di MannKind (MNKD)
- MannKind Corporation (MNKD) è una delle popolari penny stock su Robinhood da acquistare?
Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 273 filer · $560.8M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 49 (-2 vs trimestre precedente) | 38 (-9 vs trimestre precedente) | 96 (+12 vs trimestre precedente) | 62 (-7 vs trimestre precedente) | +5.4M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Rubric Capital Management LP | $76.680.000 | 18.000.000 | 13,67% | Azioni |
| STATE STREET CORP | $68.901.423 | 16.174.043 | 12,29% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $56.101.610 | 13.169.392 | 10,00% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $29.027.881 | 6.812.460 | 5,18% | Azioni |
| Frazier Life Sciences Management, L.P. | $28.116.000 | 6.600.000 | 5,01% | Azioni |
| Deep Track Capital, LP | $25.560.000 | 6.000.000 | 4,56% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $23.099.232 | 5.422.355 | 4,12% | Azioni |
| 180 WEALTH ADVISORS, LLC | $21.126.835 | 4.959.351 | 3,77% | Azioni |
| FMR LLC | $17.455.563 | 4.097.550 | 3,11% | Azioni |
| TSP Capital Management Group, LLC | $16.923.596 | 3.972.675 | 3,02% | Azioni |
| BRAIDWELL LP | $14.732.908 | 3.458.429 | 2,63% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.789.240 | 3.002.169 | 2,28% | Azioni |
| VANGUARD GROUP INC | $11.888.249 | 2.096.693 | 2,12% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $11.475.213 | 2.693.712 | 2,05% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11.070.577 | 2.598.727 | 1,97% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $9.358.279 | 2.196.779 | 1,67% | Azioni |
| BANK OF AMERICA CORP /DE/ | $8.689.749 | 2.039.847 | 1,55% | Azioni |
| GOLDMAN SACHS GROUP INC | $6.332.618 | 1.486.530 | 1,13% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.030.221 | 1.180.803 | 0,90% | Azioni |
| BlackRock, Inc. | $4.766.748 | 1.118.955 | 0,85% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $4.486.321 | 1.053.127 | 0,80% | Azioni |
| Caption Management, LLC | $4.260.000 | 1.000.000 | 0,76% | Opzione Put |
| J. Goldman & Co LP | $3.478.669 | 816.589 | 0,62% | Azioni |
| WELLS FARGO & COMPANY/MN | $3.473.987 | 815.490 | 0,62% | Azioni |
| SCOPIA CAPITAL MANAGEMENT LP | $2.960.534 | 694.961 | 0,53% | Azioni |
| Balyasny Asset Management L.P. | $2.914.296 | 684.107 | 0,52% | Azioni |
| TWO SIGMA ADVISERS, LP | $2.897.166 | 510.964 | 0,52% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $2.771.407 | 650.565 | 0,49% | Azioni |
| Swiss National Bank | $2.502.324 | 587.400 | 0,45% | Azioni |
| STATE OF WISCONSIN INVESTMENT BOARD | $2.177.052 | 511.045 | 0,39% | Azioni |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2.106.540 | 494.493 | 0,38% | Azioni |
| 1492 Capital Management LLC | $2.052.136 | 481.722 | 0,37% | Azioni |
| Mariner, LLC | $2.020.189 | 474.236 | 0,36% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $1.836.597 | 431.126 | 0,33% | Azioni |
| Schonfeld Strategic Advisors LLC | $1.774.216 | 416.483 | 0,32% | Azioni |
| Squarepoint Ops LLC | $1.759.644 | 413.062 | 0,31% | Azioni |
| Jefferies Financial Group Inc. | $1.694.202 | 397.700 | 0,30% | Azioni |
| ExodusPoint Capital Management, LP | $1.666.261 | 391.141 | 0,30% | Azioni |
| JANE STREET GROUP, LLC | $1.658.418 | 389.300 | 0,30% | Opzione Call |
| Man Group plc | $1.624.023 | 381.226 | 0,29% | Azioni |
| RHUMBLINE ADVISERS | $1.604.647 | 376.681 | 0,29% | Azioni |
| IEQ CAPITAL, LLC | $1.544.607 | 362.584 | 0,28% | Azioni |
| CITIGROUP INC | $1.499.243 | 351.935 | 0,27% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.423.692 | 334.200 | 0,25% | Opzione Put |
| Bank of New York Mellon Corp | $1.422.222 | 333.855 | 0,25% | Azioni |
| Caption Management, LLC | $1.414.231 | 331.979 | 0,25% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1.359.221 | 319.066 | 0,24% | Azioni |
| ALPS ADVISORS INC | $1.330.615 | 312.351 | 0,24% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.216.230 | 285.500 | 0,22% | Opzione Call |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.029.075 | 241.567 | 0,18% | Azioni |
| BARCLAYS PLC | $1.029.062 | 241.564 | 0,18% | Azioni |
| Rafferty Asset Management, LLC | $1.008.640 | 236.770 | 0,18% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $1.002.715 | 235.379 | 0,18% | Azioni |
| Aaron Wealth Advisors LLC | $1.000.878 | 234.948 | 0,18% | Azioni |
| HSBC HOLDINGS PLC | $998.560 | 230.881 | 0,18% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $930.294 | 379.712 | 0,17% | Azioni |
| CITADEL ADVISORS LLC | $928.680 | 218.000 | 0,17% | Opzione Call |
| CITADEL ADVISORS LLC | $898.860 | 211.000 | 0,16% | Opzione Put |
| Bruce & Co., Inc. | $831.011 | 195.073 | 0,15% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $775.060 | 181.939 | 0,14% | Azioni |
| MetLife Investment Management, LLC | $766.442 | 179.916 | 0,14% | Azioni |
| FRANKLIN RESOURCES INC | $755.021 | 177.235 | 0,13% | Azioni |
| Stonepine Capital Management, LLC | $750.000 | 250.000 | 0,13% | Opzione Call |
| UBS Group AG | $715.978 | 168.070 | 0,13% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $693.375 | 283.010 | 0,12% | Azioni |
| MORGAN STANLEY | $651.282 | 152.883 | 0,12% | Azioni |
| TUDOR INVESTMENT CORP ET AL | $640.657 | 150.389 | 0,11% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $632.009 | 148.359 | 0,11% | Azioni |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $613.437 | 171.372 | 0,11% | Azioni |
| Jain Global LLC | $604.673 | 141.942 | 0,11% | Azioni |
| KING LUTHER CAPITAL MANAGEMENT CORP | $590.457 | 138.605 | 0,11% | Azioni |
| Susquehanna Portfolio Strategies, LLC | $574.538 | 134.868 | 0,10% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $570.354 | 133.886 | 0,10% | Azioni |
| MERCER GLOBAL ADVISORS INC /ADV | $557.723 | 130.921 | 0,10% | Azioni |
| PROFUND ADVISORS LLC | $517.726 | 121.532 | 0,09% | Azioni |
| Invesco Ltd. | $512.389 | 120.279 | 0,09% | Azioni |
| Vanguard Global Advisers, LLC | $509.833 | 119.679 | 0,09% | Azioni |
| KLP KAPITALFORVALTNING AS | $491.604 | 115.400 | 0,09% | Azioni |
| Gotham Asset Management, LLC | $452.463 | 106.212 | 0,08% | Azioni |
| State of New Jersey Common Pension Fund D | $403.171 | 94.641 | 0,07% | Azioni |
| State of Wyoming | $403.149 | 94.636 | 0,07% | Azioni |
| Police & Firemen's Retirement System of New Jersey | $386.834 | 90.806 | 0,07% | Azioni |
| Amundi | $374.310 | 87.866 | 0,07% | Azioni |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $373.478 | 87.671 | 0,07% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $359.966 | 84.499 | 0,06% | Azioni |
| ARIZONA STATE RETIREMENT SYSTEM | $344.050 | 80.763 | 0,06% | Azioni |
| Mitsubishi UFJ Asset Management Co., Ltd. | $338.155 | 79.379 | 0,06% | Azioni |
| Aquatic Capital Management LLC | $335.300 | 78.709 | 0,06% | Azioni |
| Rockefeller Capital Management L.P. | $332.996 | 78.168 | 0,06% | Azioni |
| Vanguard Investments Australia, Ltd. | $314.929 | 73.927 | 0,06% | Azioni |
| JANUS HENDERSON GROUP PLC | $313.658 | 127.763 | 0,06% | Azioni |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $312.203 | 73.287 | 0,06% | Azioni |
| Sequoia Financial Advisors, LLC | $296.935 | 69.703 | 0,05% | Azioni |
| INTECH INVESTMENT MANAGEMENT LLC | $284.653 | 66.820 | 0,05% | Azioni |
| COMMONWEALTH EQUITY SERVICES, LLC | $280.421 | 65.827 | 0,05% | Azioni |
| China Universal Asset Management Co., Ltd. | $262.714 | 61.670 | 0,05% | Azioni |
| LPL Financial LLC | $260.060 | 61.047 | 0,05% | Azioni |
| SIMPLEX TRADING, LLC | $258.790 | 60.749 | 0,05% | Azioni |
| Cetera Investment Advisers | $241.546 | 56.701 | 0,04% | Azioni |
| Painted Porch Advisors LLC | $227.620 | 53.432 | 0,04% | Azioni |
Insider aziendali 43 insider · 27 dirigenti · 18 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Michael Castagna | Chief Executive Officer | 15 Luglio 2026 M | 2.433.779 | 1 | 4 | $-990.292 |
| Hakan Edstrom | President & CEO | 27 Agosto 2015 A | 1.114.340 | 0 | 0 | $0 |
| Christopher B Prentiss | Chief Financial Officer | 15 Luglio 2026 F | 318.668 | 0 | 0 | $0 |
| Juergen Martens | Corporate VP and COO | 27 Agosto 2015 A | 106.539 | 0 | 0 | $0 |
| Dominic Marasco | Pres, Endocrine Business Unit | 15 Luglio 2026 F | 343.398 | 0 | 0 | $0 |
| Sanjay R Singh | EVP Technical Operations | 15 Luglio 2026 M | 478.966 | 0 | 1 | $-94.448 |
| Stuart A Tross | Chief People & Workpl Officer | 15 Luglio 2026 M | 1.058.142 | 0 | 2 | $-548.528 |
| David Thomson | EVP Genl Counsel & Secretary | 15 Luglio 2026 M | 797.554 | 0 | 3 | $-930.755 |
| Ajay Ahuja | Chief Medical Officer | 23 Marzo 2026 A | 318.200 | 0 | 0 | $0 |
| Lauren M Sabella | EVP Operations | 15 Luglio 2025 F | 349.841 | 0 | 0 | $0 |
| Burkhard Blank | EVP Chief Medical Officer | 15 Luglio 2025 F | 460.791 | 0 | 0 | $0 |
| Joseph Kocinsky | Chief Technology Officer | 27 Agosto 2022 F | 745.233 | 0 | 0 | $0 |
| Alejandro Galindo | EVP Endocrine Business Unit | 28 Febbraio 2022 A | 576.690 | 0 | 0 | $0 |
| Rosabel Realica Alinaya | VP, IR & Treasury | 27 Agosto 2020 A | 167.119 | 0 | 0 | $0 |
| David M Kendall | Chief Medical Officer | 31 Luglio 2020 P | 41.059 | 0 | 0 | $0 |
| Patrick Mccauley | Chief Commercial Officer | 25 Febbraio 2020 A | 83.972 | 0 | 0 | $0 |
| Courtney Barton | Chief Compl & Privacy Officer | 31 Luglio 2019 P | 29.584 | 0 | 0 | $0 |
| Elizabeth Garrett Ingram | Chief Marketing Officer | 14 Maggio 2019 A | 43.012 | 0 | 0 | $0 |
| Raymond W. Urbanski | Corp VP, CMO | 10 Agosto 2017 S | 2.924 | 0 | 0 | $0 |
| Linda A Adreveno | Sr. VP, HR | 18 Febbraio 2016 A | 92.200 | 0 | 0 | $0 |
| Alfred E Mann | Executive Chairman | 22 Agosto 2015 F | 1.005.990 | 0 | 0 | $0 |
| Diane Palumbo | Vice President, Human Resource | 23 Febbraio 2015 F | 50.624 | 0 | 0 | $0 |
| Peter C Richardson | Chief Scientific Officer | 03 Marzo 2012 F | 133.611 | 0 | 0 | $0 |
| Richard L Anderson | Corporate VP | 16 Novembre 2008 F | 204.401 | 0 | 0 | $0 |
| John R. Riesenberger | VP & Chief Commercial Officer | 13 Agosto 2008 A | 14.650 | 0 | 0 | $0 |
| Dan Burns | VP & President, MKBP | 08 Dicembre 2006 A | 14.800 | 0 | 0 | $0 |
| Wendell W Cheatham | VP, Medical & Reg Affairs | 19 Agosto 2004 A | 300 | 0 | 0 | $0 |
| Sabrina Kay | Direttore | 20 Maggio 2026 A | 265.600 | 0 | 0 | $0 |
| Jennifer Grancio | Direttore | 20 Maggio 2026 A | 244.815 | 0 | 0 | $0 |
| James Samuel Shannon | Direttore | 20 Maggio 2026 A | 64.635 | 0 | 0 | $0 |
| Michael A Friedman | Direttore | 20 Maggio 2026 A | 47.500 | 0 | 0 | $0 |
| Anthony C Hooper | Direttore | 20 Maggio 2026 A | 236.153 | 0 | 0 | $0 |
| Christine Mundkur | Direttore | 20 Maggio 2026 A | 254.493 | 0 | 0 | $0 |
| Ronald J Consiglio | Direttore | 20 Maggio 2026 A | 132.342 | 0 | 0 | $0 |
| Kent Kresa | Direttore | 15 Maggio 2024 A | 274.541 | 0 | 0 | $0 |
| Henry L Nordhoff | Direttore | 14 Maggio 2019 A | 103.426 | 0 | 0 | $0 |
| David Maccallum | Direttore | 16 Maggio 2018 A | 114.790 | 0 | 0 | $0 |
| Matthew J Pfeffer | Direttore | 28 Agosto 2017 F | 81.961 | 0 | 0 | $0 |
| Abraham E Cohen | Direttore | 17 Agosto 2012 S | 56.424 | 0 | 0 | $0 |
| Heather Hay Murren | Direttore | 13 Agosto 2008 A | 10.100 | 0 | 0 | $0 |
| Kathleen Connell | Direttore | 25 Maggio 2006 A | — | 0 | 0 | $0 |
| Llew Keltner | Direttore | 25 Maggio 2006 A | — | 0 | 0 | $0 |
| Steven B. Binder | — | 07 Agosto 2026 S | 785.867 | 0 | 3 | $-427.369 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 2 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Alfred E. Mann, Alfred E. Mann Living Trust, Biomed Partners, LLC, Minimed Infusion, Inc., The Mann Group LLC ×2 depositi | 10 Luglio 2012 | — | Deposito iniziale | Investimento passivo | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 31 Gennaio 2006 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 42 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| RNIN · EA Series Trust | 1,43% | 773.251 NS | 30 Aprile 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 0,74% | 317.578 NS | 31 Maggio 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,53% | 29.662 SH | 19 Agosto 2026 | Giornaliero |
| AGNG · Global X Funds | 0,46% | 98.947 NS | 31 Maggio 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,34% | 625.921 NS | 30 Aprile 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,11% | 64.525 NS | 31 Maggio 2026 | N-PORT |
| IBB · iShares Trust | 0,09% | 2.194.293 SH | 19 Agosto 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,08% | 17.098 SH | 19 Agosto 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 330.117 SH | 19 Agosto 2026 | Giornaliero |
| IWO · iShares Trust | 0,08% | 2.783.818 SH | 19 Agosto 2026 | Giornaliero |
| PSC · Principal Exchange-Traded Funds | 0,07% | 354.917 NS | 30 Giugno 2026 | N-PORT |
| ESML · iShares Trust | 0,06% | 447.380 SH | 19 Agosto 2026 | Giornaliero |
| BIB · ProShares Trust | 0,06% | 11.389 NS | 31 Maggio 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,04% | 114.273 NS | 30 Aprile 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 1.771.496 SH | 19 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,04% | 7.900.932 SH | 19 Agosto 2026 | Giornaliero |
| ISCG · iShares Trust | 0,04% | 94.032 SH | 19 Agosto 2026 | Giornaliero |
| ITWO · ProShares Trust | 0,03% | 14.400 NS | 31 Maggio 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 132.607 NS | 30 Aprile 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 1.466.402 NS | 31 Maggio 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 61.465 NS | 31 Maggio 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,02% | 874.372 SH | 19 Agosto 2026 | Giornaliero |
| ISCB · iShares Trust | 0,02% | 13.557 SH | 19 Agosto 2026 | Giornaliero |
| UWM · ProShares Trust | 0,02% | 11.261 NS | 31 Maggio 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 135.688 NS | 30 Aprile 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 638.128 NS | 30 Aprile 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 11.390 NS | 31 Maggio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 3.543.398 SH | 19 Agosto 2026 | Giornaliero |
| WSML · iShares Trust | 0,01% | 16.464 SH | 19 Agosto 2026 | Giornaliero |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 12.000 NS | 31 Maggio 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 286 NS | 31 Maggio 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 452.118 NS | 30 Aprile 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 27.701 NS | 30 Aprile 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 466.285 SH | 19 Agosto 2026 | Giornaliero |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,00% | 1.330 NS | 31 Maggio 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 83.490 SH | 19 Agosto 2026 | Giornaliero |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 196.006 NS | 31 Maggio 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 10.345 NS | 30 Aprile 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 32.093 NS | 30 Aprile 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 14.557 NS | 30 Aprile 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 9.327.332 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 26.184 SH | 19 Agosto 2026 | Giornaliero |